These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group. Pollard SG; Lear PA; Ready AR; Moore RH; Johnson RW Transplantation; 1999 Nov; 68(9):1325-31. PubMed ID: 10573071 [TBL] [Abstract][Full Text] [Related]
23. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Campistol JM; Gutierrez-Dalmau A; Torregrosa JV Transplantation; 2004 Mar; 77(5):760-2. PubMed ID: 15021843 [TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma after renal transplantation. Abbaszadeh S; Taheri S Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):775-8. PubMed ID: 19736472 [TBL] [Abstract][Full Text] [Related]
25. Comparison of Neoral and Sandimmune cyclosporine for induction of immunosuppression after heart transplantation. Carrier M; White M; Pellerin M; Pelletier GB; Pelletier LC Can J Cardiol; 1997 May; 13(5):469-73. PubMed ID: 9179085 [TBL] [Abstract][Full Text] [Related]
27. Neoral conversion study: shift from Sandimmune classic formulation to Sandimmune Neoral in heart and lung transplant patients. Svendsen U; Larsen K; Allermand H; Thayssen P; Jensen S; Pettersson G Transplant Proc; 1995 Dec; 27(6):3477. PubMed ID: 8540057 [No Abstract] [Full Text] [Related]
28. Conversion to generic cyclosporine A in stable chronic patients after heart transplantation. Kraeuter M; Helmschrott M; Erbel C; Gleissner CA; Frankenstein L; Schmack B; Ruhparwar A; Ehlermann P; Katus HA; Doesch AO Drug Des Devel Ther; 2013; 7():1421-6. PubMed ID: 24348018 [TBL] [Abstract][Full Text] [Related]
29. A pharmacoeconomic analysis of Neoral without intravenous cyclosporine in liver transplantation in Canada. Hemming AW; Cattral MS; Greig PD; Meisner J; Turcotte L; Lilly LB; Levy GA Clin Transplant; 1998 Oct; 12(5):425-9. PubMed ID: 9787952 [TBL] [Abstract][Full Text] [Related]
30. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Montagnino G; Bencini PL; Tarantino A; Caputo R; Ponticelli C Am J Nephrol; 1994; 14(2):121-6. PubMed ID: 8080004 [TBL] [Abstract][Full Text] [Related]
31. [A single-center controlled clinical study with Sandimmune Neoral after kidney transplantation]. Matl I; Vítko S; Lácha J; Horcicková M; Nosková L; Símová M; Táborský P; Viklický O; Hulínský V; Lánská V Vnitr Lek; 1997 Nov; 43(11):703-6. PubMed ID: 9650498 [TBL] [Abstract][Full Text] [Related]
32. The evaluation of the safety and tolerability of two formulations of cyclosporine: neoral and sandimmune. A meta-analysis. Shah MB; Martin JE; Schroeder TJ; First MR Transplantation; 1999 Jun; 67(11):1411-7. PubMed ID: 10385078 [TBL] [Abstract][Full Text] [Related]
33. Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration. Gaspari F; Anedda MF; Signorini O; Remuzzi G; Perico N J Am Soc Nephrol; 1997 Apr; 8(4):647-52. PubMed ID: 10495795 [TBL] [Abstract][Full Text] [Related]
34. Renal function following conversion from Sandimmune to Neoral in stable renal transplant recipients. Bartucci M; Koshla B; Fleming-Brooks S; Weigel K; Donley V; Schulak JA; Knauss TC; Hricik DE J Transpl Coord; 1997 Jun; 7(2):78-81. PubMed ID: 9295593 [TBL] [Abstract][Full Text] [Related]
35. Comparison of generic cyclosporine microemulsion versus neoral in de novo renal transplant recipients managed by 2-hour postdose monitoring. Sharma A; Shekhar C; Heer M; Minz M Transplant Proc; 2006 Sep; 38(7):2051-3. PubMed ID: 16979996 [TBL] [Abstract][Full Text] [Related]
36. Kaposi Sarcoma in the Genital Area in a Kidney Transplant Patient: A Case Report and Literature Review. Imko-Walczuk B; Kielbowicz M; Malyszko J; Malyszko J; Barczyk M; Debska-Slizien A; Mysliwiec M; Rutkowski B Transplant Proc; 2016 Jun; 48(5):1843-8. PubMed ID: 27496505 [TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France. Farge D Eur J Med; 1993; 2(6):339-43. PubMed ID: 8252179 [TBL] [Abstract][Full Text] [Related]
38. A prospective study on conversion from sandimmune to neoral in stable adult liver transplant recipients. Jain A; Gadomski M; Fung J Dig Dis Sci; 1999 Apr; 44(4):775-7. PubMed ID: 10219837 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation. Mueller EA; Kovarik JM; van Bree JB; Lison AE; Kutz K Transplantation; 1994 Apr; 57(8):1178-82. PubMed ID: 8178343 [TBL] [Abstract][Full Text] [Related]